Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1511)
CG Oncology, Inc. (CGON)
Mulay James — Director
Shares
654
Price
$63.50
Total Value
$41.53K
Shares Held After
0
% of Holdings
100.0%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
595
Price
$24.99
Total Value
$14.87K
Shares Held After
675,610
% of Holdings
0.1%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
595
Price
$24.99
Total Value
$14.87K
Shares Held After
675,613
% of Holdings
0.1%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
1,709
Price
$61.03
Total Value
$104.30K
Shares Held After
46,149
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
Olian Judy D. — Director
Shares
200
Price
$535.44
Total Value
$107.09K
Shares Held After
4,445
% of Holdings
4.3%
EyePoint, Inc. (EYPT)
Duker Jay S. — Director
Shares
1,500
Price
$13.15
Total Value
$19.72K
Shares Held After
100,665
% of Holdings
1.5%
ABEONA THERAPEUTICS INC. (ABEO)
Vazzano Joseph Walter — Chief Financial Officer
Shares
785
Price
$4.76
Total Value
$3.74K
Shares Held After
567,775
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
516
Price
$534.99
Total Value
$276.05K
Shares Held After
8,414
% of Holdings
5.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
2,329
Price
$481.79
Total Value
$1.12M
Shares Held After
35,405
% of Holdings
6.2%
Liquidia Corp (LQDA)
SINGH RAMAN — Director
Shares
20,000
Price
$36.04
Total Value
$720.83K
Shares Held After
38,755
% of Holdings
34.0%
Liquidia Corp (LQDA)
Saggar Rajeev — Chief Medical Officer
Shares
35,365
Price
$36.30
Total Value
$1.28M
Shares Held After
174,473
% of Holdings
16.9%
Liquidia Corp (LQDA)
Krepp Sarah — Chief Human Resource Officer
Shares
16,261
Price
$38.00
Total Value
$617.92K
Shares Held After
148,397
% of Holdings
9.9%
Neurogene Inc. (NGNE)
Cobb Stuart — Chief Scientific Officer
Shares
148
Price
$22.08
Total Value
$3.27K
Shares Held After
30,497
% of Holdings
0.5%
Neurogene Inc. (NGNE)
Cobb Stuart — Chief Scientific Officer
Shares
2,658
Price
$21.34
Total Value
$56.72K
Shares Held After
30,645
% of Holdings
8.0%
Neurogene Inc. (NGNE)
Cobb Stuart — Chief Scientific Officer
Shares
3,991
Price
$20.41
Total Value
$81.46K
Shares Held After
33,303
% of Holdings
10.7%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — President and CFO
Shares
263
Price
$22.02
Total Value
$5.79K
Shares Held After
105,798
% of Holdings
0.2%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — President and CFO
Shares
1,395
Price
$21.25
Total Value
$29.64K
Shares Held After
106,061
% of Holdings
1.3%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — President and CFO
Shares
2,387
Price
$20.42
Total Value
$48.75K
Shares Held After
107,456
% of Holdings
2.2%
Stoke Therapeutics, Inc. (STOK)
LEVIN ARTHUR A — Director
Shares
605
Price
$36.80
Total Value
$22.26K
Shares Held After
4,237
% of Holdings
12.5%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
17,716
Price
$24.88
Total Value
$440.72K
Shares Held After
675,015
% of Holdings
2.6%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
17,717
Price
$24.88
Total Value
$440.74K
Shares Held After
675,018
% of Holdings
2.6%
Equillium, Inc. (EQ)
Zedelmayer Christine — Sr. Vice President and COO
Shares
120,312
Price
$2.50
Total Value
$300.82K
Shares Held After
62,586
% of Holdings
65.8%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
9,759
Price
$69.23
Total Value
$675.57K
Shares Held After
4,438,447
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
10,241
Price
$68.39
Total Value
$700.35K
Shares Held After
4,448,206
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
10,310
Price
$69.20
Total Value
$713.45K
Shares Held After
635,686
% of Holdings
1.6%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
9,690
Price
$68.36
Total Value
$662.44K
Shares Held After
645,996
% of Holdings
1.5%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
253
Price
$27.82
Total Value
$7.04K
Shares Held After
76,140
% of Holdings
0.3%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
3,079
Price
$27.37
Total Value
$84.26K
Shares Held After
76,393
% of Holdings
3.9%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
10,726
Price
$25.91
Total Value
$277.92K
Shares Held After
79,472
% of Holdings
11.9%
Zai Lab Ltd (ZLAB)
Amado Rafael — President, Head of Global Oncology Research and Development
Shares
2,957
Price
$18.63
Total Value
$55.08K
Shares Held After
44,757
% of Holdings
6.2%
Zai Lab Ltd (ZLAB)
Edmondson Frazor Titus III — Chief Legal Officer
Shares
1,281
Price
$18.63
Total Value
$23.86K
Shares Held After
6,494
% of Holdings
16.5%
Zai Lab Ltd (ZLAB)
Chen Yajing — Chief Financial Officer
Shares
1,703
Price
$18.63
Total Value
$31.72K
Shares Held After
19,999
% of Holdings
7.8%
Zai Lab Ltd (ZLAB)
Smiley Joshua L — President and Chief Operating Officer
Shares
1,966
Price
$18.63
Total Value
$36.62K
Shares Held After
91,026
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$542.03
Total Value
$43.36K
Shares Held After
130
% of Holdings
38.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$541.21
Total Value
$259.78K
Shares Held After
210
% of Holdings
69.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
865
Price
$540.27
Total Value
$467.33K
Shares Held After
690
% of Holdings
55.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,546
Price
$539.26
Total Value
$833.70K
Shares Held After
1,555
% of Holdings
49.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,019
Price
$538.31
Total Value
$1.09M
Shares Held After
3,101
% of Holdings
39.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,030
Price
$537.29
Total Value
$1.09M
Shares Held After
5,120
% of Holdings
28.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,536
Price
$536.32
Total Value
$823.79K
Shares Held After
7,150
% of Holdings
17.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
944
Price
$535.43
Total Value
$505.44K
Shares Held After
8,686
% of Holdings
9.8%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
1,703
Price
$99.71
Total Value
$169.81K
Shares Held After
65,604
% of Holdings
2.5%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
2,597
Price
$98.83
Total Value
$256.66K
Shares Held After
67,307
% of Holdings
3.7%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
804
Price
$97.89
Total Value
$78.70K
Shares Held After
69,904
% of Holdings
1.1%
Orchestra BioMed Holdings, Inc. (OBIO)
Hochman David P — Director
Shares
10,000
Price
$4.29
Total Value
$42.90K
Shares Held After
1,086,467
% of Holdings
0.9%
MBX Biosciences, Inc. (MBX)
Hawryluk P. Kent — Director
Shares
18,500
Price
$28.41
Total Value
$525.66K
Shares Held After
486,777
% of Holdings
3.8%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$12.96
Total Value
$247.02K
Shares Held After
507,934
% of Holdings
3.6%
Xenon Pharmaceuticals Inc. (XENE)
KENNEY CHRISTOPHER JOHN — Chief Medical Officer
Shares
1,410
Price
$55.23
Total Value
$77.87K
Shares Held After
7,069
% of Holdings
16.6%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
7,308
Price
$55.23
Total Value
$403.58K
Shares Held After
19,923
% of Holdings
26.8%
Xenon Pharmaceuticals Inc. (XENE)
DiFabio Andrea — Chief Legal Officer
Shares
1,342
Price
$55.23
Total Value
$74.11K
Shares Held After
7,301
% of Holdings
15.5%
Showing 451–500 of 1511 transactions (page 10 of 31)